In the published article, there was an error regarding the affiliation(s) for Sabira Mohammed. Dr Mohammed should also have an additional affiliation:
Manipal Academy of Higher Education, Manipal, India.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.
The original article has been updated.
Statements
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Summary
Keywords
FTY720, S1PR, asthma, lung diseases, sphingosine 1-phosphate, sphingosine kinase
Citation
Mohammed S and Harikumar KB (2018) Corrigendum: Sphingosine 1-Phosphate: A Novel Target for Lung Disorders. Front. Immunol. 9:1628. doi: 10.3389/fimmu.2018.01628
Received
29 June 2018
Accepted
02 July 2018
Published
17 July 2018
Approved by
Frontiers in Immunology Editorial Office, Frontiers Media SA, Switzerland
Volume
9 - 2018
Updates
Copyright
© 2018 Mohammed and Harikumar.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: K. B. Harikumar, harikumar@rgcb.res.in
Specialty section: This article was submitted to Inflammation, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.